Comments
Loading...

Kaleido Biosciences

KLDOOTCEM
Logo brought to you by Benzinga Data
$~0
At close: Nov 7, 1:16 PM EDT
Consensus Rating1
Neutral
Highest Price Target1
$1.70
Lowest Price Target1
$1.70
Consensus Price Target1
$1.70

Kaleido Biosciences (OTC:KLDO) Stock, Analyst Ratings, Price Targets, Forecasts

Kaleido Biosciences Inc has a consensus price target of $1.7 based on the ratings of 1 analysts. The high is $1.7 issued by Chardan Capital on April 4, 2022. The low is $1.7 issued by Chardan Capital on April 4, 2022. The 3 most-recent analyst ratings were released by Chardan Capital on April 4, 2022, January 31, 2022, and November 12, 2021, respectively. With an average price target of $5.23 between Chardan Capital, there's an implied 523333233.33% upside for Kaleido Biosciences Inc from these most-recent analyst ratings.

Analyst Rating and Forecast
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Chardan Capital

1calculated from analyst ratings

Analyst Ratings for Kaleido Biosciences

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Kaleido Biosciences (KLDO) stock?

A

The latest price target for Kaleido Biosciences (OTCEM:KLDO) was reported by Chardan Capital on April 4, 2022. The analyst firm set a price target for $1.70 expecting KLDO to rise to within 12 months (a possible 169999900.00% upside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Kaleido Biosciences (KLDO)?

A

The latest analyst rating for Kaleido Biosciences (OTCEM:KLDO) was provided by Chardan Capital, and Kaleido Biosciences downgraded their neutral rating.

Q

When was the last upgrade for Kaleido Biosciences (KLDO)?

A

There is no last upgrade for Kaleido Biosciences

Q

When was the last downgrade for Kaleido Biosciences (KLDO)?

A

The last downgrade for Kaleido Biosciences Inc happened on April 4, 2022 when Chardan Capital changed their price target from $3 to $1.7 for Kaleido Biosciences Inc.

Q

When is the next analyst rating going to be posted or updated for Kaleido Biosciences (KLDO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kaleido Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kaleido Biosciences was filed on April 4, 2022 so you should expect the next rating to be made available sometime around April 4, 2023.

Q

Is the Analyst Rating Kaleido Biosciences (KLDO) correct?

A

While ratings are subjective and will change, the latest Kaleido Biosciences (KLDO) rating was a downgraded with a price target of $3.00 to $1.70. The current price Kaleido Biosciences (KLDO) is trading at is $0.00, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.